In the News

For press inquiries:

Ritedose Announces Launch of New Unit Dose Syringe Product: Succinylcholine Chloride Injection 200 mg/10 mL (20 mg/mL)

COLUMBIA, S.C. (March 25, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Succinylcholine Chloride Injection 200 mg/10 mL (20 mg/mL). It is the first of 12 Ritedose products expected to hit the market over the next six months for hospital pharmacies across the country. Ritedose is a division of The Ritedose Corporation, a 25-year-leader in cGMP drug manufacturing for major pharmaceutical companies and research development programs.

Read More »

New pavilion in Columbia to serve as e-learning location for homeless children

COLUMBIA, S.C. (COLA DAILY) — The Columbia-based nonprofit, Homeless No More, unveiled a new pavilion Thursday morning to serve as a shady spot for families and children to gather. It will be available to the families using the organization’s emergency/transitional housing services.

The funding for the structure was provided by The Ritedose Corporation, a pharmaceutical company in Columbia. Homeless No More CEO Lila Anna Sauls said Ritedose quickly responded when they found out the need for the covered pavilion, after having been a generous donor for years.

Read More »

As surge in evictions loom, Columbia non-profit expands resources

COLUMBIA, S.C. (WIS) – For the non-profit Homeless No More, Thursday was an opportunity to celebrate.

The organization, which provides emergency, transitional, and low-cost housing for those struggling with homelessness, hosted a ribbon-cutting for a new pavilion at its complex, funded by The Ritedose Corporation.

Read More »

Pioneers in aseptic production of sterile, single-dose medication